DanCann Pharma A/S postpones quarterly report for Q2 2022
COPENHAGEN, Denmark, 19 August 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the board of directors of DanCann Pharma has decided to postpone the report for the second quarter until Wednesday, August 31, 2022. The previous date was set for August 25, 2022.About DanCann Pharma DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution Company based in Denmark.